FDA approves Mylan's generic Zofran

06/25/2007 | Forbes

Mylan Laboratories won FDA approval of its generic version of GlaxoSmithKline's anti-nausea drug Zofran, prescribed for cancer patients in chemotherapy. Mylan said it plans to begin shipping its product immediately.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ